Obesity remains a highly prevalent chronic health concern in primary care patients in the United States. A large percentage of patients struggle to lose weight with changes to health and lifestyle interventions alone. Consideration of current data findings in four separate studies suggests the addition of phentermine therapy may assist patients diagnosed with obesity.
A literature search led to the decision to use quantitative health evaluations at 1 month, 2 months, and 3 months of phentermine therapy. Baseline health and prior intervention with lifestyle modification will be evaluated prior to the start of therapy. Weight and body mass index will be recorded at each health evaluation to determine the total amount of weight lost. Multivariable linear models can be used to compare weight loss at the 1-month, 2-month, and 3-month marks. A review of the literature concluded patients saw a 5-10% bodyweight reduction within the first 3 months of therapy. The addition of phentermine therapy along with diet and lifestyle modifications may result in weight loss when utilized for a 3-month period.